GE HEALTHCARE TECHNOLOGY (GEHC) Fundamental Analysis & Valuation

NASDAQ:GEHC • US36266G1076

Current stock price

70.77 USD
+0.44 (+0.63%)
At close:
70.8865 USD
+0.12 (+0.16%)
After Hours:

This GEHC fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. GEHC Profitability Analysis

1.1 Basic Checks

  • In the past year GEHC was profitable.
  • In the past year GEHC had a positive cash flow from operations.
  • Each year in the past 5 years GEHC has been profitable.
  • In the past 5 years GEHC always reported a positive cash flow from operatings.
GEHC Yearly Net Income VS EBIT VS OCF VS FCFGEHC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

1.2 Ratios

  • GEHC has a Return On Assets of 5.65%. This is amongst the best in the industry. GEHC outperforms 81.52% of its industry peers.
  • GEHC has a better Return On Equity (20.09%) than 94.57% of its industry peers.
  • GEHC has a Return On Invested Capital of 7.81%. This is amongst the best in the industry. GEHC outperforms 82.07% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for GEHC is in line with the industry average of 9.18%.
Industry RankSector Rank
ROA 5.65%
ROE 20.09%
ROIC 7.81%
ROA(3y)5.31%
ROA(5y)6.29%
ROE(3y)21.03%
ROE(5y)19.41%
ROIC(3y)8.25%
ROIC(5y)9.14%
GEHC Yearly ROA, ROE, ROICGEHC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

1.3 Margins

  • GEHC has a better Profit Margin (10.11%) than 83.15% of its industry peers.
  • GEHC's Profit Margin has declined in the last couple of years.
  • GEHC has a Operating Margin of 13.40%. This is amongst the best in the industry. GEHC outperforms 80.43% of its industry peers.
  • GEHC's Operating Margin has declined in the last couple of years.
  • With a Gross Margin value of 39.98%, GEHC is not doing good in the industry: 67.39% of the companies in the same industry are doing better.
  • In the last couple of years the Gross Margin of GEHC has remained more or less at the same level.
Industry RankSector Rank
OM 13.4%
PM (TTM) 10.11%
GM 39.98%
OM growth 3Y-0.87%
OM growth 5Y-3.3%
PM growth 3Y-1.1%
PM growth 5Y-34%
GM growth 3Y0.71%
GM growth 5Y0.28%
GEHC Yearly Profit, Operating, Gross MarginsGEHC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. GEHC Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so GEHC is destroying value.
  • Compared to 1 year ago, GEHC has less shares outstanding
  • The number of shares outstanding for GEHC has been increased compared to 5 years ago.
  • GEHC has about the same debt/assets ratio as last year.
GEHC Yearly Shares OutstandingGEHC Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M
GEHC Yearly Total Debt VS Total AssetsGEHC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2025 10B 20B 30B

2.2 Solvency

  • An Altman-Z score of 1.85 indicates that GEHC is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • GEHC's Altman-Z score of 1.85 is in line compared to the rest of the industry. GEHC outperforms 57.61% of its industry peers.
  • GEHC has a debt to FCF ratio of 6.67. This is a slightly negative value and a sign of low solvency as GEHC would need 6.67 years to pay back of all of its debts.
  • GEHC has a Debt to FCF ratio of 6.67. This is in the better half of the industry: GEHC outperforms 75.54% of its industry peers.
  • A Debt/Equity ratio of 0.92 indicates that GEHC is somewhat dependend on debt financing.
  • GEHC has a Debt to Equity ratio of 0.92. This is in the lower half of the industry: GEHC underperforms 73.91% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.92
Debt/FCF 6.67
Altman-Z 1.85
ROIC/WACC0.8
WACC9.78%
GEHC Yearly LT Debt VS Equity VS FCFGEHC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

2.3 Liquidity

  • A Current Ratio of 1.37 indicates that GEHC should not have too much problems paying its short term obligations.
  • GEHC has a worse Current ratio (1.37) than 78.26% of its industry peers.
  • A Quick Ratio of 1.13 indicates that GEHC should not have too much problems paying its short term obligations.
  • The Quick ratio of GEHC (1.13) is worse than 73.37% of its industry peers.
Industry RankSector Rank
Current Ratio 1.37
Quick Ratio 1.13
GEHC Yearly Current Assets VS Current LiabilitesGEHC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. GEHC Growth Analysis

3.1 Past

  • The Earnings Per Share has been growing slightly by 2.00% over the past year.
  • The earnings per share for GEHC have been decreasing by -31.63% on average. This is quite bad
  • Looking at the last year, GEHC shows a small growth in Revenue. The Revenue has grown by 4.85% in the last year.
  • The Revenue has been growing slightly by 3.74% on average over the past years.
EPS 1Y (TTM)2%
EPS 3Y2.54%
EPS 5Y-31.63%
EPS Q2Q%-0.69%
Revenue 1Y (TTM)4.85%
Revenue growth 3Y3.99%
Revenue growth 5Y3.74%
Sales Q2Q%7.13%

3.2 Future

  • Based on estimates for the next years, GEHC will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.20% on average per year.
  • GEHC is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.05% yearly.
EPS Next Y12.85%
EPS Next 2Y11.37%
EPS Next 3Y11.08%
EPS Next 5Y8.2%
Revenue Next Year5.48%
Revenue Next 2Y4.99%
Revenue Next 3Y4.9%
Revenue Next 5Y4.05%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
GEHC Yearly Revenue VS EstimatesGEHC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5B 10B 15B 20B 25B
GEHC Yearly EPS VS EstimatesGEHC Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

7

4. GEHC Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 15.45, GEHC is valued correctly.
  • GEHC's Price/Earnings ratio is rather cheap when compared to the industry. GEHC is cheaper than 85.33% of the companies in the same industry.
  • The average S&P500 Price/Earnings ratio is at 25.71. GEHC is valued slightly cheaper when compared to this.
  • Based on the Price/Forward Earnings ratio of 13.69, the valuation of GEHC can be described as correct.
  • Based on the Price/Forward Earnings ratio, GEHC is valued cheaply inside the industry as 88.04% of the companies are valued more expensively.
  • GEHC is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 23.83, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 15.45
Fwd PE 13.69
GEHC Price Earnings VS Forward Price EarningsGEHC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • 88.04% of the companies in the same industry are more expensive than GEHC, based on the Enterprise Value to EBITDA ratio.
  • Based on the Price/Free Cash Flow ratio, GEHC is valued cheaply inside the industry as 86.41% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 21.43
EV/EBITDA 11.32
GEHC Per share dataGEHC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

  • GEHC's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • The decent profitability rating of GEHC may justify a higher PE ratio.
PEG (NY)1.2
PEG (5Y)N/A
EPS Next 2Y11.37%
EPS Next 3Y11.08%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

3

5. GEHC Dividend Analysis

5.1 Amount

  • With a yearly dividend of 0.20%, GEHC is not a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 0.22, GEHC pays a better dividend. On top of this GEHC pays more dividend than 89.67% of the companies listed in the same industry.
  • With a Dividend Yield of 0.20, GEHC pays less dividend than the S&P500 average, which is at 1.91.
Industry RankSector Rank
Dividend Yield 0.2%

5.2 History

  • GEHC has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
GEHC Yearly Dividends per shareGEHC Yearly Dividends per shareYearly Dividends per share 2023 2024 2025 2026 0.05 0.1 0.15

5.3 Sustainability

  • GEHC pays out 3.07% of its income as dividend. This is a sustainable payout ratio.
DP3.07%
EPS Next 2Y11.37%
EPS Next 3Y11.08%
GEHC Yearly Income VS Free CF VS DividendGEHC Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B
GEHC Dividend Payout.GEHC Dividend Payout, showing the Payout Ratio.GEHC Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

GEHC Fundamentals: All Metrics, Ratios and Statistics

GE HEALTHCARE TECHNOLOGY

NASDAQ:GEHC (3/13/2026, 8:00:00 PM)

After market: 70.8865 +0.12 (+0.16%)

70.77

+0.44 (+0.63%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-04
Earnings (Next)04-27
Inst Owners93.29%
Inst Owner Change12.34%
Ins Owners0.3%
Ins Owner Change0.63%
Market Cap32.25B
Revenue(TTM)20.63B
Net Income(TTM)2.08B
Analysts78.57
Price Target95.29 (34.65%)
Short Float %2.2%
Short Ratio3.04
Dividend
Industry RankSector Rank
Dividend Yield 0.2%
Yearly Dividend0.14
Dividend Growth(5Y)N/A
DP3.07%
Div Incr Years1
Div Non Decr Years1
Ex-Date04-02
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.4%
Min EPS beat(2)-0.16%
Max EPS beat(2)0.96%
EPS beat(4)3
Avg EPS beat(4)5.61%
Min EPS beat(4)-0.16%
Max EPS beat(4)13.24%
EPS beat(8)6
Avg EPS beat(8)4.83%
EPS beat(12)10
Avg EPS beat(12)5.31%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-0.59%
Min Revenue beat(2)-0.75%
Max Revenue beat(2)-0.44%
Revenue beat(4)1
Avg Revenue beat(4)-0.46%
Min Revenue beat(4)-1.09%
Max Revenue beat(4)0.42%
Revenue beat(8)1
Avg Revenue beat(8)-1.72%
Revenue beat(12)2
Avg Revenue beat(12)-1.42%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.3%
PT rev (3m)6.38%
EPS NQ rev (1m)0%
EPS NQ rev (3m)4.69%
EPS NY rev (1m)2.9%
EPS NY rev (3m)3.15%
Revenue NQ rev (1m)0.14%
Revenue NQ rev (3m)0.61%
Revenue NY rev (1m)1.1%
Revenue NY rev (3m)1.14%
Valuation
Industry RankSector Rank
PE 15.45
Fwd PE 13.69
P/S 1.56
P/FCF 21.43
P/OCF 16.23
P/B 3.11
P/tB N/A
EV/EBITDA 11.32
EPS(TTM)4.58
EY6.47%
EPS(NY)5.17
Fwd EY7.3%
FCF(TTM)3.3
FCFY4.67%
OCF(TTM)4.36
OCFY6.16%
SpS45.26
BVpS22.77
TBVpS-9.3
PEG (NY)1.2
PEG (5Y)N/A
Graham Number48.44
Profitability
Industry RankSector Rank
ROA 5.65%
ROE 20.09%
ROCE 9.94%
ROIC 7.81%
ROICexc 9.32%
ROICexgc 25%
OM 13.4%
PM (TTM) 10.11%
GM 39.98%
FCFM 7.3%
ROA(3y)5.31%
ROA(5y)6.29%
ROE(3y)21.03%
ROE(5y)19.41%
ROIC(3y)8.25%
ROIC(5y)9.14%
ROICexc(3y)9.48%
ROICexc(5y)10.1%
ROICexgc(3y)28.41%
ROICexgc(5y)36.05%
ROCE(3y)10.49%
ROCE(5y)11.63%
ROICexgc growth 3Y-16.74%
ROICexgc growth 5Y-17.72%
ROICexc growth 3Y-3.85%
ROICexc growth 5Y-6.16%
OM growth 3Y-0.87%
OM growth 5Y-3.3%
PM growth 3Y-1.1%
PM growth 5Y-34%
GM growth 3Y0.71%
GM growth 5Y0.28%
F-Score4
Asset Turnover0.56
Health
Industry RankSector Rank
Debt/Equity 0.92
Debt/FCF 6.67
Debt/EBITDA 2.85
Cap/Depr 83.39%
Cap/Sales 2.34%
Interest Coverage 5.29
Cash Conversion 59.47%
Profit Quality 72.18%
Current Ratio 1.37
Quick Ratio 1.13
Altman-Z 1.85
F-Score4
WACC9.78%
ROIC/WACC0.8
Cap/Depr(3y)71.99%
Cap/Depr(5y)60.92%
Cap/Sales(3y)2.12%
Cap/Sales(5y)1.89%
Profit Quality(3y)91.25%
Profit Quality(5y)85.67%
High Growth Momentum
Growth
EPS 1Y (TTM)2%
EPS 3Y2.54%
EPS 5Y-31.63%
EPS Q2Q%-0.69%
EPS Next Y12.85%
EPS Next 2Y11.37%
EPS Next 3Y11.08%
EPS Next 5Y8.2%
Revenue 1Y (TTM)4.85%
Revenue growth 3Y3.99%
Revenue growth 5Y3.74%
Sales Q2Q%7.13%
Revenue Next Year5.48%
Revenue Next 2Y4.99%
Revenue Next 3Y4.9%
Revenue Next 5Y4.05%
EBIT growth 1Y5.26%
EBIT growth 3Y3.09%
EBIT growth 5Y0.31%
EBIT Next Year31.3%
EBIT Next 3Y14.92%
EBIT Next 5Y12.12%
FCF growth 1Y-2.9%
FCF growth 3Y-5.84%
FCF growth 5Y-8.6%
OCF growth 1Y1.85%
OCF growth 3Y-2.03%
OCF growth 5Y-5.37%

GE HEALTHCARE TECHNOLOGY / GEHC Fundamental Analysis FAQ

What is the fundamental rating for GEHC stock?

ChartMill assigns a fundamental rating of 5 / 10 to GEHC.


What is the valuation status for GEHC stock?

ChartMill assigns a valuation rating of 7 / 10 to GE HEALTHCARE TECHNOLOGY (GEHC). This can be considered as Undervalued.


How profitable is GE HEALTHCARE TECHNOLOGY (GEHC) stock?

GE HEALTHCARE TECHNOLOGY (GEHC) has a profitability rating of 7 / 10.


What is the financial health of GE HEALTHCARE TECHNOLOGY (GEHC) stock?

The financial health rating of GE HEALTHCARE TECHNOLOGY (GEHC) is 3 / 10.


Can you provide the dividend sustainability for GEHC stock?

The dividend rating of GE HEALTHCARE TECHNOLOGY (GEHC) is 3 / 10 and the dividend payout ratio is 3.07%.